Phil expresses his hesitation about investing in medical devices, citing a lack of expertise in the sector. He emphasizes the importance of having a solid go-to-market strategy and suggests that the product may need more traction before attracting his investment. Daniel appreciates the product's potential but also feels it's too early for him to commit, indicating interest for future rounds if the startup gains more positive feedback.
